5% stakes
Balyasny Asset Management
Institution
- 5% stake reports
- 41
- 5% stake stocks
- 27
- Latest report
- 26/08/14
5% stake reports
| Stock | ||
|---|---|---|
| Beyond Air XAIR08/14 | 5.3%763,266 sh | −1.9pp |
| Sagimet Biosciences SGMT08/14 | 5.93%3,626,113 sh | First report |
| Rezolute RZLT08/14 | 4.84%4,662,039 sh | −0.4pp |
| Rallybio RLYB08/14 | 0%0 sh | −7.1pp |
| Research Alliance Corp III RACC08/14 | 6.43%500,000 sh | First report |
| Quince Therapeutics QNCX08/14 | 9.99%97,699 sh | First report |
| Ovid Therapeutics OVID08/14 | 4.99%9,313,341 sh | −0.3pp |
| Neurogene NGNE08/14 | 5.18%818,706 sh | First report |
| Jatt II Acquisition JATT08/14 | 6.23%500,000 sh | First report |
| Korsana Biosciences KRSA08/14 | 7.33%317,511 sh | First report |
| Cellectar Biosciences CLRB08/14 | 9.99%798,382 sh | First report |
| Camp4 Therapeutics CAMP08/14 | 4.99%2,591,097 sh | −0.1pp |
| Contineum Therapeutics CTNM05/15 | 7.4%2,417,723 sh | −0.2pp |
| Helix Acquisition Corp. III HLXC05/15 | 6.97%1,237,500 sh | First report |
| Rezolute RZLT05/15 | 5.28%5,048,421 sh | First report |
| Ovid Therapeutics OVID05/15 | 5.33%7,029,223 sh | First report |
| Crescent Biopharma CBIO05/15 | 5.48%1,510,033 sh | First report |
| Camp4 Therapeutics CAMP05/15 | 5.07%2,632,437 sh | First report |
| SAB Biotherapeutics SABS05/15 | 9.99%5,089,939 sh | First report |
| Beyond Air XAIR05/15 | 7.25%763,266 sh | −2.3pp |
